SAG protects human neuroblastoma SH-SY5Y cells against 1-methyl-4-phenylpyridinium ion (MPP+)-induced cytotoxicity via the downregulation of ROS generation and JNK signaling

被引:32
作者
Kim, Sun-Yee
Kim, Mi-Yeon
Mo, Jung-Soon
Park, Jeen-Woo
Park, Hee-Sae
机构
[1] Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea
[2] Kyungpook Natl Univ, Coll Nat Sci, Dept Biochem, Taegu 702701, South Korea
基金
新加坡国家研究基金会;
关键词
Parkinson's disease; MPP+; SAG; JNK1; SH-SY5Y human neuroblastoma; cell viability;
D O I
10.1016/j.neulet.2006.11.074
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Sensitive to anoptosis gene (SAG), a novel zinc RING finger protein, exhibits anti-apoptotic and antioxidant activity against a variety of redox reagents. In the present study, we have determined that SAG suppresses 1-methyl-4-phenylpyridinium ion (MPP+)-induced neurotoxicity via the downregulation of ROS generation and c-Jun N-terminal kinase 1 (JNK1) activity. Both transient and constitutively overexpressed SAG were found to inhibit the MPP+-induced neurotoxicity of SH-SY5Y neuroblastoma cells. In the SAG-expressing cells, MPP+ induced ROS generation was suppressed to a significant degree as compared to the cells treated only with MPP+. MPP+-induced JNK1 activation was also determined to be suppressed markedly by SAG. Furthermore, SAG inhibits MEKK1 dependent c-Jun transcription activity in SH-SY5Y cells. Thus, we concluded that SAG is a cellular protective molecule, which appears to function as an antioxidant, suppressing MPP+-induced neurotoxicity. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:132 / 136
页数:5
相关论文
共 33 条
[11]  
Huang YH, 2001, MOL CARCINOGEN, V30, P62, DOI 10.1002/1098-2744(200101)30:1<62::AID-MC1014>3.0.CO
[12]  
2-A
[13]   Thiol-linked peroxidase activity of human sensitive to apoptosis gene (SAG) protein [J].
Kim, SY ;
Bae, YS ;
Park, JW .
FREE RADICAL RESEARCH, 2002, 36 (01) :73-78
[14]   Phosphorylation of threonine 10 on CKBBP1/SAG/ROC2/Rbx2 by protein kinase CKII promotes the degradation of IκBα and p27Kip1 [J].
Kim, YS ;
Lee, JY ;
Son, MY ;
Park, W ;
Bae, YS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (31) :28462-28469
[15]   1-METHYL-4-PHENYLPYRIDINIUM ION (MPP+) - IDENTIFICATION OF A METABOLITE OF MPTP, A TOXIN SELECTIVE TO THE SUBSTANTIA NIGRA [J].
LANGSTON, JW ;
IRWIN, I ;
LANGSTON, EB ;
FORNO, LS .
NEUROSCIENCE LETTERS, 1984, 48 (01) :87-92
[16]   PARKINSONS-DISEASE [J].
MARSDEN, CD .
LANCET, 1990, 335 (8695) :948-952
[17]   Molecular pathophysiology of Parkinson's disease [J].
Moore, DJ ;
West, AB ;
Dawson, VL ;
Dawson, TM .
ANNUAL REVIEW OF NEUROSCIENCE, 2005, 28 :57-87
[18]   Genetics of Parkinson's disease [J].
Morris, HR .
ANNALS OF MEDICINE, 2005, 37 (02) :86-96
[19]   Hsp72 functions as a natural inhibitory protein of c-Jun N-terminal kinase [J].
Park, HS ;
Lee, JS ;
Huh, SH ;
Seo, JS ;
Choi, EJ .
EMBO JOURNAL, 2001, 20 (03) :446-456
[20]   DOPAMINE RECEPTOR INTERACTIONS - SOME IMPLICATIONS FOR THE TREATMENT OF PARKINSONS-DISEASE [J].
ROBERTSON, HA .
TRENDS IN NEUROSCIENCES, 1992, 15 (06) :201-206